AgeX Therapeutics Inc. (AMEX: AGE) is 65.79% higher on its value in year-to-date trading and has touched a low of $0.67 and a high of $3.93 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The AGE stock was last observed hovering at around $2.18 in the last trading session, with the day’s gains setting it 0.34%.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Currently trading at $2.52, the stock is 11.86% and 30.57% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.56 million and changing 15.60% at the moment leaves the stock 82.09% off its SMA200. AGE registered 115.38% gain for a year compared to 6-month gain of 165.26%. The firm has a 50-day simple moving average (SMA 50) of $2.0876 and a 200-day simple moving average (SMA200) of $1.5700.
The stock witnessed a 44.83% loss in the last 1 month and extending the period to 3 months gives it a 41.57%, and is 16.67% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.47% over the week and 11.04% over the month.
AgeX Therapeutics Inc. (AGE) has around 17 employees, a market worth around $99.04M and $1.90M in sales. Distance from 52-week low is 278.38% and -35.88% from its 52-week high. The company has generated returns on investments over the last 12 months (-343.40%).
AgeX Therapeutics Inc. (AGE) Analyst Forecasts
The EPS is expected to shrink by -51.80% this year.
AgeX Therapeutics Inc. (AGE) Top Institutional Holders
48 institutions hold shares in AgeX Therapeutics Inc. (AGE), with 16.48M shares held by insiders accounting for 43.72% while institutional investors hold 32.50% of the company’s shares. The shares outstanding are 37.68M, and float is at 21.21M with Short Float at 1.92%. Institutions hold 18.29% of the Float.
The top institutional shareholder in the company is Broadwood Capital, Inc. with over 3.0 million shares valued at $4.56 million. The investor’s holdings represent 7.95% of the AGE Shares outstanding. As of Dec 30, 2020, the second largest holder is Vanguard Group, Inc. (The) with 0.65 million shares valued at $0.98 million to account for 1.72% of the shares outstanding. The other top investors are Bridgeway Capital Management, Inc. which holds 0.2 million shares representing 0.54% and valued at over $0.31 million, while Prescott General Partners LLC holds 0.49% of the shares totaling 0.19 million with a market value of $0.28 million.
AgeX Therapeutics Inc. (AGE) Insider Activity
A total of 4 insider transactions have happened at AgeX Therapeutics Inc. (AGE) in the last six months, with sales accounting for 2 and purchases happening 2 times.